(0.14%) 5 138.50 points
(0.07%) 38 469 points
(0.23%) 17 887 points
(-0.21%) $83.67
(1.82%) $1.958
(0.10%) $2 349.50
(0.46%) $27.66
(1.48%) $935.75
(-0.12%) $0.934
(-0.24%) $11.00
(-0.22%) $0.799
(1.22%) $92.99
40.94% HKD 1.790
Live Chart Being Loaded With Signals
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 13.96M |
Średni wolumen | 476 561 |
Kapitalizacja rynkowa | 750.60M |
EPS | HKD0 ( 2023-08-24 ) |
Last Dividend | HKD1.497 ( 2021-09-13 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 13.77 |
ATR14 | HKD0.0150 (0.84%) |
Wolumen Korelacja
Lansen Pharmaceutical Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lansen Pharmaceutical Korelacja - Waluta/Towar
Lansen Pharmaceutical Finanse
Annual | 2022 |
Przychody: | HKD65.56M |
Zysk brutto: | HKD44.30M (67.57 %) |
EPS: | HKD0.0205 |
FY | 2022 |
Przychody: | HKD65.56M |
Zysk brutto: | HKD44.30M (67.57 %) |
EPS: | HKD0.0205 |
FY | 2021 |
Przychody: | HKD54.18M |
Zysk brutto: | HKD34.41M (63.51 %) |
EPS: | HKD0.00224 |
FY | 2020 |
Przychody: | HKD54.39M |
Zysk brutto: | HKD35.18M (64.68 %) |
EPS: | HKD0.218 |
Financial Reports:
No articles found.
Lansen Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0136 | 2011-04-20 |
Last Dividend | HKD1.497 | 2021-09-13 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | HKD2.55 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.25 | -- |
Div. Sustainability Score | 8.21 | |
Div.Growth Potential Score | 2.16 | |
Div. Directional Score | 5.19 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3998.HK | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
1811.HK | Ex Dividend Junior | 2023-06-06 | Sporadic | 0 | 0.00% | |
0839.HK | Ex Dividend Knight | 2023-06-09 | Semi-Annually | 0 | 0.00% | |
0004.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
2388.HK | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
1378.HK | Ex Dividend Knight | 2023-11-16 | Annually | 0 | 0.00% | |
0440.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
6820.HK | No Dividend Player | 2023-05-18 | Annually | 0 | 0.00% | |
1929.HK | Ex Dividend Knight | 2023-07-12 | Semi-Annually | 0 | 0.00% | |
0956.HK | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.114 | 1.500 | 7.72 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0424 | 1.200 | 8.59 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0604 | 1.500 | -0.440 | -0.661 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.28 | 1.820 | [1 - 3] |
quickRatioTTM | 1.500 | 0.800 | 5.88 | 4.71 | [0.8 - 2.5] |
cashRatioTTM | 0.939 | 1.500 | 5.89 | 8.84 | [0.2 - 2] |
debtRatioTTM | 0.101 | -1.500 | 8.31 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.00596 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00460 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.144 | -1.500 | 9.43 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.660 | 1.000 | 2.33 | 2.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.191 | 1.000 | 8.18 | 8.18 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.142 | 1.000 | -0.323 | -0.323 | [0.2 - 2] |
assetTurnoverTTM | 0.371 | 0.800 | -0.859 | -0.687 | [0.5 - 2] |
Total Score | 8.21 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.03 | 1.000 | 8.78 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0604 | 2.50 | -0.283 | -0.661 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00460 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.00596 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00938 | 1.500 | -3.27 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0388 | 1.000 | -1.530 | 0 | [0.1 - 0.5] |
Total Score | 2.16 |
Lansen Pharmaceutical
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej